Brett Sandercock - 17 Feb 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
17 Feb 2023
Transactions value $
-$2,152,196
Form type
4
Filing time
22 Feb 2023, 15:21:37 UTC
Previous filing
14 Feb 2023
Next filing
10 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$2.15M -10K -8.56% $215.22 107K 17 Feb 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 This transaction was executed in multiple trades at prices ranging from $215.00 - $215.59. The price reported above reflects the weighted average sale price.